Zimmer Biomet Holdings, Inc.
94.61USD
+0.3900 (+0.41%)
Revenue
| (USD) | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| FY | 6.9B | 7.4B | 7.7B | 8.2B | 8.6B | 8.9B |
| Q1 | 1.7B | 1.8B | 1.9B | 1.9B | 2.1B | — |
| Q2 | 1.8B | 1.9B | 1.9B | 2.1B | 2.2B | — |
| Q3 | 1.7B | 1.8B | 1.8B | 2.0B | 2.0B | — |
| Q4 | 1.8B* | 1.9B* | 2.0B* | 2.2B* | 2.3B | — |
Revenue
| (USD) | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| FY | 1.10 | 4.88 | 4.43 | 3.55 | 8.53 | 9.07 |
| Q1 | .070 | 1.11 | .840 | .910 | 1.22 | — |
| Q2 | .730 | 1.00 | 1.18 | .770 | 1.03 | — |
| Q3 | .920 | .770 | 1.23 | 1.16 | 1.88 | — |
| Q4 | -.621* |
Fiscal period: Reported, Estimated. Reported figures: SEC filings (EDGAR). Estimates are sell-side consensus for periods that have not reported. Cells marked * were synthesized from the annual filing less the year-to-date figures, because the quarter was not filed on its own. Earnings per share are restated onto today's share basis, so a period before a stock split is comparable with the ones after it.
| 2.00* |
| 1.17* |
| .701* |
| 2.49 |
| — |